OpGen

OpGen develops and commercializes rapid molecular diagnostic systems to detect pathogens and antimicrobial resistance markers. Its Unyvero system offers syndromic testing panels for lower respiratory tract and urinary tract infections. The Acuitas AMR Gene Panel detects antimicrobial resistance genes directly from patient samples. The company’s products are used to guide antibiotic therapy selection in hospitals to improve outcomes in patients with severe or drug-resistant bacterial infections. Clinical data support the accuracy and speed of these tests compared to traditional culture methods; however, detailed recent trial results are not specified in public summaries.